A Managed Care Review on Insomnia: Treatment Guidelines, Emerging Therapies, and the Need for Safe, Effective Options

The approval of lenacapavir, a form of pre-exposure prophylaxis (PrEP), marks significant progress in preventing HIV, making it vital for the treatment to be available and accessible to those most vulnerable, explains Colleen Kelley, MD, MPH, Rollins School of Public Health at Emory University.

Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.

Dupilumab was approved by the FDA to treat bullous pemphigoid, that demonstrated its efficacy in achieving sustained disease remission and significantly improving symptoms like itch and disease severity in adults.

A quick roundup episode of major news and health policy developments from The American Journal of Managed Care.

Venetoclax demonstrated impressive efficacy in octogenarians with CLL, although treatment management posed some challenges.